Literature DB >> 24195032

Effects of intraocular rifampicin on retinal ganglion cell structure: a stereological and histopathological study.

Ozgür Cakici1, Selina Aksak, Deniz Unal, Sare Sipal, Sadullah Keles, Talha Dumlu, Murat Karamese.   

Abstract

AIM: To determine the histopathological changes of rifampicin applied intravitreally on retinal ganglion cells by means of stereological and histopathological methods.
METHODS: For this study twenty-four New Zealand adult rabbits were divided into four groups (n=6 for each group). 50µg/0.1mL (group 1), 100µg/0.1mL (group 2), 150µg/0.1mL (group 3) and 200µg/0.1mL (group 4), rifampicin were injected into the vitreous of the right eyes of animals, their left eyes were used as control (group 5). After the 28(th) day of application, animals were anesthetised with xylazine (8mg/kg, IM) and then their eyes were enucleated immediately. Patterns were taken away and eyes were prepared for both stereological and electromicroscopic observation.
RESULTS: Depending on the high dose of rifampicin, some histopathological changes such as cytoplasmic dilatation and damaged membrane were observed on the electromicroscopic level. Using quantitative examination, which was done at the light microscopic level, it was shown that the number of neurons decreased linearly as rifampicin dose increased when compared with the control group.
CONCLUSION: Based on these findings, low-dose rifampicin (50µg/0.1mL) may be useful for treatment of the ocular diseases.

Entities:  

Keywords:  ganglion cells; histopathology; rifampicin; stereology

Year:  2013        PMID: 24195032      PMCID: PMC3808904          DOI: 10.3980/j.issn.2222-3959.2013.05.08

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  19 in total

1.  Mitochondrial localization of glucocortocoid receptor in glial (Müller) cells in the salamander retina.

Authors:  Anna-Maria G Psarra; Marie-Luce Bochaton-Piallat; Giulio Gabbiani; Constantine E Sekeris; Marcos Tsacopoulos
Journal:  Glia       Date:  2003-01       Impact factor: 7.452

2.  Neurofibrillary tangles and senile plaques in brain of elderly leprosy patients.

Authors:  Y Namba; K Kawatsu; S Izumi; A Ueki; K Ikeda
Journal:  Lancet       Date:  1992-10-17       Impact factor: 79.321

Review 3.  Ocular tuberculosis.

Authors:  Matthew J Thompson; Daniel M Albert
Journal:  Arch Ophthalmol       Date:  2005-06

4.  Pharmacokinetics of intravitreal vancomycin in normal and infected rabbit eyes.

Authors:  R M Coco; M I López; J C Pastor; M J Nozal
Journal:  J Ocul Pharmacol Ther       Date:  1998-12       Impact factor: 2.671

5.  A dose-ranging study of daily maintenance intravenous foscarnet therapy for cytomegalovirus retinitis in AIDS.

Authors:  M A Jacobson; D Causey; B Polsky; D Hardy; M Chown; R Davis; J J O'Donnell; B D Kuppermann; M H Heinemann; G N Holland
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

6.  Ocular toxicity from ethambutol.

Authors:  G J Barron; L Tepper; G Iovine
Journal:  Am J Ophthalmol       Date:  1974-02       Impact factor: 5.258

7.  Prevention of photoreceptor apoptosis by activation of the glucocorticoid receptor.

Authors:  A Wenzel; C Grimm; M W Seeliger; G Jaissle; F Hafezi; R Kretschmer; E Zrenner; C E Remé
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-06       Impact factor: 4.799

8.  The antibiotic rifampicin is a nonsteroidal ligand and activator of the human glucocorticoid receptor.

Authors:  C Calleja; J M Pascussi; J C Mani; P Maurel; M J Vilarem
Journal:  Nat Med       Date:  1998-01       Impact factor: 53.440

9.  Ethambutol is toxic to retinal ganglion cells via an excitotoxic pathway.

Authors:  J E Heng; C K Vorwerk; E Lessell; D Zurakowski; L A Levin; E B Dreyer
Journal:  Invest Ophthalmol Vis Sci       Date:  1999-01       Impact factor: 4.799

10.  Penetration of rifampicin into the brain tissue and cerebral extracellular space of rats.

Authors:  T Mindermann; H Landolt; W Zimmerli; Z Rajacic; O Gratzl
Journal:  J Antimicrob Chemother       Date:  1993-05       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.